Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Ferrari

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Revue Medicale Suisse|April 17, 2025
[Bone fragility management in diabetic patients]Emmanuel Biver, Maria Papageorgiou, Serge Ferrari
Therapeutic Advances in Musculoskeletal Disease|March 4, 2017
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosisBente Langdahl, Serge Ferrari, David W Dempster
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 2: Sequential osteoporosis therapy]Christian Meier, Judith Everts-Graber, Serge Ferrari
Current Medical Research and Opinion|February 6, 2014
Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifeneJean-Yves Reginster, Serge Ferrari, Peyman Hadji
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 1: Antiresorptive and osteoanabolic therapy options]Serge Ferrari, Judith Everts-Graber, Christian Meier
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2005
beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioidsAmyaouch Bradaïa, Frédérique Berton, Serge Ferrari, et al.
Revue Medicale Suisse|January 22, 2026
[Metabolic bone diseases : what's new in 2025]Ivan Padlina, Andrea Trombetti, Serge Ferrari, et al.
Bone Reports|February 24, 2026
Fracture prediction using 3D-DXA-finite element based femoral strength: a prospective study in postmenopausal womenYvan Gugler, Philippe Zysset, Serge Ferrari, et al.
Swiss Medical Weekly|October 10, 2020
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)Serge Ferrari, Kurt Lippuner, Olivier Lamy, et al.
Bone|December 15, 2010
Denosumab and bisphosphonates: different mechanisms of action and effectsRoland Baron, Serge Ferrari, R Graham G Russell
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Revue Medicale Suisse|April 17, 2025
[Bone fragility management in diabetic patients]Emmanuel Biver, Maria Papageorgiou, Serge Ferrari
Therapeutic Advances in Musculoskeletal Disease|March 4, 2017
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosisBente Langdahl, Serge Ferrari, David W Dempster
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 2: Sequential osteoporosis therapy]Christian Meier, Judith Everts-Graber, Serge Ferrari
Current Medical Research and Opinion|February 6, 2014
Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifeneJean-Yves Reginster, Serge Ferrari, Peyman Hadji
Therapeutische Umschau. Revue Therapeutique|March 17, 2025
[Osteoporosis therapy - Update 2025, Part 1: Antiresorptive and osteoanabolic therapy options]Serge Ferrari, Judith Everts-Graber, Christian Meier
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2005
beta-Arrestin2, interacting with phosphodiesterase 4, regulates synaptic release probability and presynaptic inhibition by opioidsAmyaouch Bradaïa, Frédérique Berton, Serge Ferrari, et al.
Revue Medicale Suisse|January 22, 2026
[Metabolic bone diseases : what's new in 2025]Ivan Padlina, Andrea Trombetti, Serge Ferrari, et al.
Bone Reports|February 24, 2026
Fracture prediction using 3D-DXA-finite element based femoral strength: a prospective study in postmenopausal womenYvan Gugler, Philippe Zysset, Serge Ferrari, et al.
Swiss Medical Weekly|October 10, 2020
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)Serge Ferrari, Kurt Lippuner, Olivier Lamy, et al.
Bone|December 15, 2010
Denosumab and bisphosphonates: different mechanisms of action and effectsRoland Baron, Serge Ferrari, R Graham G Russell
Pageof 18